IR
63
5
NKE
31
-5
WMT
55
-4
FOXA
66
2
ZTS
25
4
DOV
63
-6
OXY
42
2
FTI
64
-5
ALLE
46
2
EOG
37
4
MNST
59
3
PFG
55
2
WU
38
-9
CVX
28
3
USB
68
2
ROP
42
4
MS
76
2
STZ
48
6
BRK.B
40
7
SRE
47
2
IR
63
5
NKE
31
-5
WMT
55
-4
FOXA
66
2
ZTS
25
4
DOV
63
-6
OXY
42
2
FTI
64
-5
ALLE
46
2
EOG
37
4
MNST
59
3
PFG
55
2
WU
38
-9
CVX
28
3
USB
68
2
ROP
42
4
MS
76
2
STZ
48
6
BRK.B
40
7
SRE
47
2
Financhill
Back

Sarepta Therapeutics, Inc. Vs. Triumph Financial, Inc. Industry Stock Comparison

Sell
42

SRPT
Sarepta Therapeutics, Inc.

Last Price:
$21.69
Seasonality Move:
10.38%
Buy
70

TFIN
Triumph Financial, Inc.

Last Price:
$64.99
Seasonality Move:
2.9%
Sell
42
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.23. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Triumph Financial, Inc. (TFIN) is a Buy

Is Triumph Financial, Inc. a Buy, Sell or Hold?

  • The current Triumph Financial, Inc. [TFIN] share price is $65.04. The Score for TFIN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • TFIN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics, Inc.'s stock price today?

  • The Sarepta Therapeutics, Inc. share price today is $21.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

TFIN Stock Price Chart

What is Triumph Financial, Inc.'s stock price today?

  • The Triumph Financial, Inc. share price today is $65.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 52.08 Buy
Chaikin Money Flow: 241834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.51 - 22.31) Buy
Bollinger Bands (100): (17.63 - 22.21) Buy

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.17 Buy
Relative Strength Index (14 RSI): 66.64 Buy
Chaikin Money Flow: 233281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.47 - 62.71) Buy
Bollinger Bands (100): (51.28 - 60.66) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.36 Sell
20-day SMA: 21.24 Sell
50-day SMA: 20.76 Buy
200-day SMA: 31.65 Sell
8-day EMA: 13.3 Buy
20-day EMA: 6.91 Buy
50-day EMA: 3.1 Buy
200-day EMA: 0.82 Buy

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.83 Buy
20-day SMA: 59.8 Buy
50-day SMA: 56.35 Buy
200-day SMA: 57.01 Buy
8-day EMA: 40.41 Buy
20-day EMA: 21.01 Buy
50-day EMA: 9.41 Buy
200-day EMA: 2.5 Buy

Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.

Triumph Financial, Inc. Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $1.18 per share.

Sarepta Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):